Can a med spa in Vermont offer compounded semaglutide or tirzepatide?

Facility · part of The Practice Perimeter

Short answer
The cited rules do not settle this — none of them address compounded GLP-1s. They do establish that compounding is a separately licensed class of drug outlet, and that offering to prescribe, order, or administer any drug is the practice of medicine.

Vermont licenses compounding and 503B outsourcing as classes of drug outlet: Each drug outlet shall apply for a license in one or more of the following classifications: (1) Retail. (2) Institutional. (3) Manufacturer. (4) Wholesale distributor. (5) Investigative and research projects. (6) Compounding. (7) Outsourcing. (8) Home infusion. (9) Nuclear. (10) Third-party logistics provider.

Vt. Stat. tit. 26, §2061(b) (Drug outlets — registration and licensure classifications) · verified Sep 7, 2026 · regulatory monitoring, not legal advice

Related Vermont rules

All 9 cited Vermont rules on med-spa registration & licensing →

How other states answer this

All 51 states side by side →

Related Vermont questions

Every Vermont question we can answer →

Get Vermont changes as they publish

We scan the Vermont legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.

Free · unsubscribe in one click · we never sell your address

← All Vermont rules and changes · MedSpaRadar is regulatory monitoring and reference: it summarizes public laws, regulations and agency actions and links each to its source. It is not legal, medical, or compliance advice, and using it creates no attorney-client relationship. A summary can lag its source or leave out detail, and monitoring itself can be interrupted — so an absence of alerts means nothing reached you, not that nothing happened. Read the cited source, check its effective date, and confirm any change to your operations or clinical practice with qualified health-law counsel and your medical director. Legislative data via LegiScan (CC BY 4.0).